Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

The seed extract of Lepidium sativum L. can potentially treat hair loss, showing effects similar to 5% minoxidil.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

A higher testosterone/dihydrotestosterone ratio in PCOS patients may indicate worse metabolic health.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Combining low-dose dutasteride with finasteride improved a man's hair loss.

Neurosteroids help control dopamine responses in the brain.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Finasteride may effectively reduce Tourette's syndrome symptoms and improve life quality.

Herbal alternatives like saw palmetto and green tea may offer safe, effective treatment for hormonal hair loss.

Hair restoration surgery techniques have evolved, with focus on patient selection and realistic goals, and future advancements may include cloning and gene therapy.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

BLH308, made from persimmon leaf, green tea, and sophora fruit, may help reduce hair loss by fighting oxidative stress and inflammation.